MedPath

珠海联邦生物医药有限公司

Ownership
-
Established
2021-05-18
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Liraglutide Injection

Product Name
利拉鲁肽注射液
Approval Number
国药准字S20250014
Approval Date
Mar 18, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.